Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Mallinckrodt
McKesson
Medtronic
Chubb
Argus Health
Julphar
Cantor Fitzgerald
US Army

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,939,033

« Back to Dashboard

Which drugs does patent 6,939,033 protect, and when does it expire?

Patent 6,939,033 protects VIVITROL and is included in one NDA.

This patent has twenty patent family members in ten countries.
Summary for Patent: 6,939,033
Title: Method and apparatus for preparing microparticles using in-line solvent extraction
Abstract:Apparatus and method for preparing microparticles using in-line solvent extraction. An emulsion is formed by combining two phases in a static mixer. The emulsion is combined with an extraction liquid in a blending static mixer. The outflow of the blending static mixer is combined with additional extraction liquid. The additional extraction liquid and the outflow of the blending static mixer can be combined in a vessel, or through the use of a static mixer manifold that includes a plurality of static mixers.
Inventor(s): Lyons; Shawn L. (Cincinnati, OH), Wright; Steven G. (Madeira, OH)
Assignee: Alkermes Controlled Therapeutics, Inc. II (Cambridge, MA)
Application Number:10/729,909
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 6,939,033

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Alkermes VIVITROL naltrexone FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 021897-001 Apr 13, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,939,033

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,331,317 Apparatus and method for preparing microparticles ➤ Sign Up
6,537,586 Apparatus and method for preparing microparticles ➤ Sign Up
7,300,671 Method and apparatus for preparing microparticles using in-line solvent extraction ➤ Sign Up
6,540,393 Apparatus for preparing microparticles using in-line solvent extraction ➤ Sign Up
6,713,090 Apparatus and method for preparing microparticles ➤ Sign Up
7,510,730 Apparatus and method for preparing microparticles using in-line solvent extraction ➤ Sign Up
6,861,016 Apparatus and method for preparing microparticles ➤ Sign Up
6,705,757 Method and apparatus for preparing microparticles using in-line solvent extraction ➤ Sign Up
6,395,304 Apparatus and method for preparing microparticles ➤ Sign Up
6,495,166 Apparatus and method for preparing microparticles using in-line solvent extraction ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,939,033

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Portugal 1242053 ➤ Sign Up
Portugal 1231898 ➤ Sign Up
Japan 4838471 ➤ Sign Up
Japan 2003513905 ➤ Sign Up
Japan 4146639 ➤ Sign Up
Japan 2003513710 ➤ Sign Up
Spain 2277867 ➤ Sign Up
Spain 2236035 ➤ Sign Up
European Patent Office 1242053 ➤ Sign Up
European Patent Office 1231898 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Argus Health
Express Scripts
Covington
Julphar
Mallinckrodt
Merck
Farmers Insurance
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot